The Valley Desk

NCT01444417 · Interventional trial

Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

Overall registry status Completed

Phase 3

Conditions Idiopathic Thrombocytopenic Purpura, Immune Thrombocytopenia, Thrombocytopenia, Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP), Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP), Thrombocytopenic Purpura

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov